B
BiomX Inc. (PHGE)
ASE – Real vaqt narxi. Valyuta: USD
0.40
+0.00 (0.15%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.42
+0.02 (6.14%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.40
+0.00 (0.15%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.42
+0.02 (6.14%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
BiomX Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, surunkali kasalliklar bilan bog'liq muayyan zararli bakteriyalarni nishonga olish va o'ldirish uchun mo'ljallangan tabiiy va muhandislik qilingan fag texnologiyalaridan foydalangan holda fag asosidagi terapiyalarni ishlab chiqadi. Kompaniyaning fag asosidagi terapiyalari quyidagilarni o'z ichiga oladi: qat'iy kokteyl terapiyasi, bu bakterial shtammlarning bir qismini qoplash uchun belgilangan miqdordagi tanlangan faglarni o'z ichiga olgan bitta mahsulotni ishlab chiqishni o'z ichiga oladi; va shaxsiy terapiya, bu muayyan bemorlarni davolash uchun bitta optimal faglar shaxsiy ravishda moslashtirilgan faglar katta kutubxonasini ishlab chiqishni o'z ichiga oladi. U diabetik oyoq infektsiyalarini davolash uchun 2a bosqichida bo'lgan qat'iy ko'p fagli kokteyl BX011; va diabetik oyoq osteomielitini davolash uchun 2-bosqich sinovlarida bo'lgan fag terapiyasi BX211ni ishlab chiqadi. BiomX Inc. 2015-yilda tashkil etilgan va Delaver shtatining Dover shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Carl R. Merril M.D. | Scientific Founder |
| Dr. Eran Elinav M.D., Ph.D. | Scientific Founder |
| Dr. Timothy K. Lu M.D., Ph.D. | Scientific Founder |
| Mr. David Rokach | CFO, Principal Financial Officer & Principal Accounting Officer |
| Mr. Michael Oster | CEO & Director |
| Mr. Roy Timor-Rousso | Chief Business Officer |
| Ms. Marina Wolfson CPA | Secretary |
| Prof. Rotem Sorek Ph.D. | Scientific Founder |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-26 | 8-K | ea0296083-8k_biomx.htm |
| 2026-06-22 | DEFA14A | ea0295528-defa14a_biomx.htm |
| 2026-06-18 | 8-K | ea0295251-8k_biomx.htm |
| 2026-06-12 | 8-K/A | ea0293407-8ka1_biomx.htm |
| 2026-06-12 | 8-K | ea0294507-8k_biomx.htm |
| 2026-06-08 | DEF 14A | ea0293461-def14a_biomx.htm |
| 2026-06-05 | 8-K | ea0293750-8k_biomx.htm |
| 2026-05-28 | 8-K | ea0292479-8k_biomx.htm |
| 2026-05-20 | 10-Q | ea0291120-10q_biomxinc.htm |
| 2026-05-15 | NT 10-Q | ea0290878-nt10q_biomx.htm |